Cencora Inc. has announced the amendment and restatement of its existing Revolving Credit Facility. The updated agreement, effective as of June 4, 2025, involves Cencora and its subsidiaries, BP Pharmaceuticals Laboratories Unlimited Company and Innomar Strategies Inc., in collaboration with several lenders, including JPMorgan Chase Bank, N.A. as the administrative agent. Key changes to the facility include an increase in the total commitment to $4.5 billion and an extension of the maturity date to June 4, 2030. Additionally, certain covenants and provisions have been revised. The involved lenders and their affiliates have a history of providing various financial services to Cencora and may continue to do so in the future.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。